HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AN 204 (AN 201)

structure in first source
Also Known As:
AN 201; 2-pyrrolino-DOX; 2-pyrrolinodoxorubicin; 3'-deamino-3'-(2''-pyrroline-1''-yl)doxorubicin trifluoroacetate; AN-201; AN-204
Networked: 46 relevant articles (5 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Schally, Andrew V: 23 articles (01/2011 - 02/2002)
2. Nagy, Attila: 18 articles (06/2006 - 02/2002)
3. Halmos, Gabor: 16 articles (06/2007 - 02/2002)
4. Schally, A V: 11 articles (05/2008 - 02/2000)
5. Nagy, A: 10 articles (01/2002 - 02/2000)
6. Halmos, G: 9 articles (09/2001 - 02/2000)
7. Szepeshazi, Karoly: 7 articles (06/2007 - 02/2002)
8. Keller, Gunhild: 7 articles (07/2006 - 05/2005)
9. Engel, Jörg B: 6 articles (07/2006 - 05/2005)
10. Baker, Benjamin: 5 articles (07/2006 - 08/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Prostatic Neoplasms (Prostate Cancer)
3. Leukopenia
4. Hepatocellular Carcinoma (Hepatoma)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. AN 207
2. AN 238
3. Doxorubicin (Adriamycin)
4. Gonadotropin-Releasing Hormone (GnRH)
5. Somatostatin (Somatotropin Release-Inhibiting Factor)
6. lysine(6)-doxorubicin LHRH
7. LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
8. Capsules (Microcapsules)
9. RC 121
10. Estrogens (Estrogen)

Related Therapies and Procedures

1. Therapeutics
2. Injections
3. Drug Therapy (Chemotherapy)
4. Aftercare (After-Treatment)
5. Intravenous Injections